首页> 美国卫生研究院文献>BMJ Open >Efficacy and safety of levetiracetam in children with epilepsy: protocol for an umbrella review of systematic reviews and meta-analyses of randomised controlled trials
【2h】

Efficacy and safety of levetiracetam in children with epilepsy: protocol for an umbrella review of systematic reviews and meta-analyses of randomised controlled trials

机译:左乙拉西坦在癫痫儿童中的疗效和安全性:对系统评价和随机对照试验的荟萃分析进行总体评估的方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionEpilepsy causes serious suffering in children and is associated with high morbidity and increased mortality. It impairs children’s quality of life and places a heavy burden on healthcare resources. Levetiracetam has been used to prevent and treat paediatric epilepsy for years. To date, a number of systematic reviews have been performed to assess the efficacy and safety of levetiracetam in a variety of clinical settings. Conflicting outcomes have been reported for the same clinical issues. Our objective is to provide a comprehensive overview of the literature for clinicians and policymakers via an umbrella review that assesses the efficacy and safety of levetiracetam in children with epilepsy.
机译:简介癫痫病会导致儿童严重痛苦,并伴有高发病率和高死亡率。这会损害儿童的生活质量,并给医疗资源带来沉重负担。左乙拉西坦多年来一直用于预防和治疗小儿癫痫。迄今为止,已经进行了许多系统评价,以评估左乙拉西坦在各种临床环境中的疗效和安全性。对于相同的临床问题,已经报道了矛盾的结果。我们的目标是通过全面评估为左乙拉西坦治疗癫痫儿童的有效性和安全性,为临床医生和决策者提供文献综述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号